Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China
Open Access
- 13 July 2013
- journal article
- clinical trial
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 11 (1) , 155
Abstract
Background: The incidence of adenocarcinoma of the esophagogastric junction is increasing. This study aims to evaluate the clinicopathological features of Chinese patients with adenocarcinoma of the esophagogastric junction and to define prognostic factors. Methods: We retrospectively reviewed a database of 382 consecutive patients with adenocarcinoma of the esophagogastric junction at the First Affiliated Hospital of Xi’an Jiaotong University from January 2005 to March 2010. All patients were classified according to the Siewert’s classification and staged according to the latest edition of the American Joint Committee on Cancer categories. Results: Six of the 382 patients had type I adenocarcinoma, 220 had type II, and 156 had type III. There was no significant difference in the overall survival of different Siewert subtypes. According to the multivariate analysis, pathological lymph node stage, age, and the existence of lymphovascular invasion were the independent factors of prognosis of adenocarcinoma of the esophagogastric junction following surgery. Conclusions: On the data, the distribution of the three types of tumor was found to be different from that reported in Western countries. Lymph node metastasis, lymphovascular invasion, and age were significant and independent factors for poor prognosis after R0 resection for adenocarcinoma of the esophagogastric junction.Keywords
This publication has 19 references indexed in Scilit:
- How to Classify Adenocarcinomas of the Esophagogastric JunctionAmerican Journal of Surgical Pathology, 2011
- Clinicopathological Features and Prognostic Factors of Adenocarcinoma of the Esophagogastric Junction According to Siewert Classification: Experiences at a Single Institution in JapanAnnals of Surgical Oncology, 2011
- Differential Pathologic Variables and Outcomes across the Spectrum of Adenocarcinoma of the Esophagogastric JunctionWorld Journal of Surgery, 2010
- Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategiesGastric Cancer, 2010
- Esophagogastric Junction Adenocarcinoma According to Siewert Classification in TaiwanAnnals of Surgical Oncology, 2009
- Adenocarcinoma of the Esophagogastric Junction in China According to Siewert's ClassificationJapanese Journal of Clinical Oncology, 2006
- Body Mass Index and Adenocarcinomas of the Esophagus or Gastric Cardia: A Systematic Review and Meta-analysisCancer Epidemiology, Biomarkers & Prevention, 2006
- Biologic and clinical variations of adenocarcinoma at the esophago–gastric junction: Relevance of a topographic‐anatomic subclassificationJournal of Surgical Oncology, 2005
- Lymphatic Vessel Invasion As a Prognostic Factor in Patients With Primary Resected Adenocarcinomas of the Esophagogastric JunctionJournal of Clinical Oncology, 2005
- Classification of adenocarcinoma of the oesophagogastric junctionBritish Journal of Surgery, 1998